{
    "success": true,
    "data": {
        "complex": true,
        "derivatives": true,
        "swaps": false,
        "inverse": false,
        "replication_method": "physical",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [
            "Derivative use for direct investment purposes",
            "Counterparty risk from derivatives and securities lending"
        ],
        "classification": "complex",
        "supporting_data": "The iShares FTSE 250 UCITS ETF benefits from the general UCITS presumption of non-complexity due to its regulatory framework and primarily uses an optimized physical replication method to track the transparent FTSE 250 Index. However, the Key Investor Information document explicitly states that Financial Derivative Instruments (FDIs) 'may be used for direct investment purposes' and 'to help achieve the Fundu2019s investment objective'. This goes beyond simple efficient portfolio management (EPM) and suggests that derivatives are an inherent element of the fund's strategy, which, according to the provided MiFID II rules (Rule 2), classifies the ETF as complex. Furthermore, the document identifies 'Counterparty Risk' as a 'Particular risk not adequately captured by the risk indicator', specifically mentioning it in relation to 'derivatives or other instruments' and 'safekeeping of assets' (implying securities lending). The MiFID II rules emphasize that even limited derivative use can be flagged as complex by regulators if it introduces counterparty risk that is difficult for retail investors to understand. The presence of this explicit counterparty risk, stemming from derivatives and securities lending, makes the ETF's overall structure and associated risks opaque and not easily comprehensible for an average retail investor, thereby overturning the initial UCITS non-complex presumption. The ETF is rated 6/7 on the risk scale, and while market risk itself isn't complexity, the identified counterparty risk is a structural complexity that contributes to this higher risk profile and classification."
    }
}